We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Research data published in JAMA Internal Medicine reveal that a proposal by the administration of US President Donald Trump that would require drugmakers to disclose list prices in certain ads has a significant loophole, CNN reported Tuesday.